Background: Coronavirus disease 2019 (COVID-19) is associated with increased
thrombosis prevalence. However, there are insufficient data supporting the appropriate …

The COVID-19 is a pandemic disease caused by SARS-CoV-2 and is associated with high
degree of morbidity and mortality, which are also dependent upon thrombotic complications …

The novel coronavirus disease 2019 (COVID‐19), is currently the leading threat to public
health and a huge challenge to the healthcare systems across the globe and caused by …

2 Vascular Medicine 00 (0) most current guidelines. Both the International Society of
Thrombosis and Haemostasis (ISTH) and the European guidelines do not recommend …

Since the beginning of the SARS-CoV-2 (COVID-19) pandemic, correlation of venous
thromboembolism (VTE) and COVID-19 infection has been well established. Increased …

Background: Characterizing the multiorgan manifestations and outcomes of patients
hospitalized with COVID-19 will inform resource requirements to address the long-term …

Introduction There are no clear data about the incidence and the prophylactic strategies of
arterial and venous thromboembolic events (TE) in COVID-19 ambulatory patients. Thus, we …

Cervera et al. with the analysis of the SEMI-COVID-19 registry with the finding of an
admission D-dimer> 3.0 μg/mL as a strong predictor for venous thromboembolism (VTE) in …

Thromboembolism is the third leading vascular disease, with a high annual incidence of 1 to
2 cases per 1000 individuals within the general population. The broader term venous …

Objective There is a paucity of data on how race affects the clinical presentation and short-
term outcome among hospitalized patients with SARS-CoV-2, the 2019 coronavirus (COVID …